Jie Wang

Qiqihar University — China

Medicine · Health Sciences

57h-index17.7kcitations648works4.22yr avg

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lung Cancer Treatments and Mutations(203), Cancer Immunotherapy and Biomarkers(166), Lung Cancer Research Studies(111), Cancer Genomics and Diagnostics(85), Lung Cancer Diagnosis and Treatment(61)

Publications645 total

Surface Reconstruction and Orthogonal Decoupling in SrAl <sub>4</sub> and EuAl <sub>4</sub>

ACS Nano·2025

Analysis of factors associated with substandard nutrition in critically ill patients and the effect of applying enteral nutrition nursing model based on evidence-based medicine: A retrospective observational study

Medicine·2025Open Access

Modified Bidirectional Projection Technique for Spherical Fuzzy MAGDM and Applications to Demand Evaluation for Public Sports Services for the Elderly in Rural Areas

International Journal of Fuzzy Systems·2025

Bilateral primary breast angiosarcoma: A rare case and therapeutic insight

Asian Journal of Surgery·2025Open Access

Study of the blood–brain barrier-penetrating KRAS G12C inhibitor JMKX1899 in KRAS G12C-mutated NSCLC with brain metastases

Journal of the National Cancer Center·2025Open Access

Regulatory effects of row spacing on plant-soil feedbacks in an oat-forage pea intercropping system: a two-year, dual-location study

BMC Plant Biology·2025Open Access

Isomerization-engineered ESIPT-based probe for dynamic glutathione imaging in liver injury

Journal of Molecular Structure·2025

MiroThinker: Pushing the Performance Boundaries of Open-Source Research Agents via Model, Context, and Interactive Scaling

arXiv (Cornell University)·2025Open Access

Tumor-associated macrophages (CD68+) as a potential prognostic biomarker for PD-1 inhibitor response in relapsed/refractory classical Hodgkin lymphoma

Blood·2025Open Access

Long-term outcomes and clinical features of stage III non-small-cell lung cancer harboring ALK rearrangements: a multicenter retrospective study of 176 patients

Journal of the National Cancer Center·2025Open Access

Unraveling the active ingredients and molecular mechanisms of Qinghua Changyan granule against irritable bowel syndrome with diarrhea: Effects on gut microbiota and glutamine transport via an integrative approach combining UHPLC-MS/MS and experimental verification

1 cited

Fitoterapia·2025· 1 cited

Anti‐PD‐1 Nanobody‐Armored MSLN CAR‐T Therapy for Malignant Mesothelioma: Preclinical and Clinical Studies

1 cited

Advanced Science·2025· 1 citedOpen Access

Long-term outcomes of postoperative radiotherapy for patients with pIIIA-N2 non-small-cell lung cancer after complete resection and adjuvant chemotherapy (PORT-C): a single-centre, randomized, phase 3 trial

EClinicalMedicine·2025Open Access

Structural evolutions, electronic structures and nonlinear optical properties of Ce6Sn0/− (n = 1–11) clusters: A density functional theory investigation

Theoretical Chemistry Accounts·2025

PL02.09 Aumolertinib plus Chemotherapy for NSCLC with EGFR and Concomitant Tumor Suppressor Genes (ACROSS 2): Phase III study

Journal of Thoracic Oncology·2025

P2.10.14 Individualized Neoantigen Therapy With Unusual Radiotherapy Enhancement (iNATURE) a Phase II Randomized Study

Journal of Thoracic Oncology·2025

First-Line Tislelizumab Plus Chemotherapy in Advanced Non-Squamous Non-Small Cell Lung Cancer: PD-L1 ≥ 50% Subgroup Analysis from the RATIONALE-304 Trial

Oncology and Therapy·2025Open Access

WITHDRAWN: 1865P Association between immune-related adverse events and clinical outcomes in non-small cell lung cancer patients treated with chemo-immunotherapy: A post hoc analysis of the phase III choice-01 trial

Annals of Oncology·2025

2135P FS-1502 in patients with HER2 expression, locally advanced or metastatic gastric or gastroesophageal junction adenocarcinoma (GC/GEJ): An open-label, multicenter, phase II study

Annals of Oncology·2025Open Access

Burden of chemotherapy-induced myelosuppression (CIM) in Chinese patients with extensive-stage small cell lung cancer (ES-SCLC): A retrospective real-world study

Chinese Medical Journal - Pulmonary and Critical Care Medicine·2025Open Access

page 1 of 33Next →

Frequent Co-authors

Zhijie Wang(19), Yi‐Long Wu(8), Caicun Zhou(7), Shun Lü(7), Jianchun Duan(7), Shuhang Wang(7), Ying Cheng(7), Jun Zhao(6), Hua Bai(6), Jie He(6), Shangli Cai(5), Yanhua Tian(5), Jianying Zhou(5), Xingya Li(5), Kailun Fei(5), Gongyan Chen(4), Chengping Hu(4), Qiming Wang(4), Xiaochen Zhao(4), Yuzi Zhang(4)